Playbook · Sourcing
How to find a co-manufacturer for supplements in Germany — a 2026 buyer's guide
A supplement co-manufacturer is a contract producer that manufactures food-supplement products under GMP standards on behalf of a brand owner. In Germany, the supplement category — Nahrungsergänzungsmittel or NEM — sits inside food law, not pharma law, but the operational bar is closer to pharma than to confectionery. Germany hosts an estimated 120–150 active supplement contract manufacturers in 2026, and the gap between the strongest and the weakest is wider than any other European market.
Most brand-side teams approach the shortlist the wrong way: they Google "best supplement manufacturer Germany", collect twenty business cards at Vitafoods, send an unstructured RFQ to the longest list, and then spend the next four months reconciling apples-to-pears quotes. This playbook documents the structured approach we use inside every Supplier Matrix engagement at Lila Zebra — including the regulatory bar, the certifications that actually matter, the realistic MOQ and capacity ranges, and the six-step workflow that lands a signature-ready shortlist in roughly fourteen working days.
Why this sourcing problem is harder than it looks
The German supplement category was worth roughly €2.3 billion at retail in 2024 and has compounded at mid-single digits since the pandemic, according to Statista's published category data. That growth has pulled in new brand-side entrants — pharma carve-outs, D2C scale-ups, retail private-label initiatives — most of whom have never managed a contract-manufacturing relationship in this category.
The category looks straightforward from the outside. It is, in practice, governed by an overlapping triple-layer of rules: EU food law (Regulation EC 178/2002 as horizontal framework, plus the Food Supplements Directive 2002/46/EC); German national law (LFGB and the supplement-specific Nahrungsergänzungsmittelverordnung, NemV); and EU claims and novel-food regulation (Regulation EC 1924/2006 on health claims, with 247 approved Article 13(1) health claims; plus Regulation EU 2015/2283 for novel foods). Pharmacy-channel products layer further pharmacy-specific obligations on top.
The brand-side teams who get burned tend to make two specific mistakes. First, they let the spec stay loose until a manufacturer is selected, which gives the CMO de-facto control of the formula. Second, they confuse "certification" with "fit for purpose". A manufacturer holding only ISO 9001 may pass a procurement checklist but cannot ship into a German retailer demanding IFS Food. The cost of correcting these two mistakes once a contract is signed is typically €40,000–€120,000 in lost runway and reformulation work.
What to look for in a German supplement CMO
The criteria below are the screening dimensions we score every candidate on. Each one is binary at first pass — does this manufacturer clear the bar? — then weighted in a second-pass scorecard.
Certification stack
For retail distribution (drugstores, supermarkets, online): IFS Food at Higher Level or FSSC 22000 is the de-facto floor in 2026. Bio-claim products additionally require an EU organic certifier (DE-ÖKO-001 through 070). Pharmacy-channel products typically require the manufacturer to hold a §11a AMG registration even if the product itself is not a medicinal product, plus the finished good must carry a PZN (Pharmazentralnummer). Vegan or kosher claims require independently audited certification — manufacturer self-declaration does not survive retailer audits anymore.
Format and capacity
Capsules (HPMC, gelatine), tablets (uncoated, coated, sustained-release), powders (single-serve sachets, jars), softgels, gummies and effervescents each require dedicated filling lines. Few German CMOs run all six formats. If your forecast volume sits at 80% of the manufacturer's installed line capacity, you become a high-priority customer; at 5%, you become a slot they de-prioritise during peak season.
Audit and CAPA history
Ask for the last two IFS or FSSC audit summaries (not just the certificate), the open CAPA list, and any BVL incident notes. In our experience across 80+ German CMO conversations, manufacturers with zero open CAPAs deliver on-time at ~94% reliability; those with three or more open items drop below 70%.
Raw-material provenance
The 2026 rule of thumb: any active ingredient sourced outside the EU and EEA needs a documented chain of custody, a recent Certificate of Analysis from an accredited lab, and ideally a TRACES (Trade Control and Expert System) registration where applicable. Manufacturers who buy raw materials through opaque wholesalers will not be able to defend the chain when a retailer audits.
The six-step process
This is the workflow we execute inside every Supplier Matrix engagement. Each step has a hard exit criterion — a finished output that gates the next step.
1. Lock the product specification
Before talking to any manufacturer, document format, dosage, target claims, label language, target retail price, intended channel and the regulatory pathway. A specification that fits on one A4 page is sufficient; a loose specification — "we want a gut-health product, maybe capsules" — triples the size of the candidate list and wastes weeks.
2. Filter by GMP regime
Decide which certification stack you actually need. For drugstore listing in DM/Rossmann/Müller: IFS Food + ISO 22000. For pharmacy distribution: add §11a AMG and PZN. For health-food-shop channels (Reformhaus, Bio): organic certifier. Filter the candidate universe before any direct outreach.
3. Map capacity and format range
Match your 12-month forecast against the manufacturer's installed line capacity for your specific format. A manufacturer running a single capsule line at 80% utilisation has different incentives than one running three lines at 40%.
4. Verify audit history
Request the most recent two IFS or FSSC audit summaries, the open CAPA list, and any BVL incident log. This is the single most predictive signal of on-time delivery — more than price, more than capacity, more than claims expertise.
5. Stress-test the formulation
Ask each finalist to confirm your formula in writing — including raw-material origin, allergen handling, novel-food status, and a stability indication (a documented projection of the shelf-life claim). Verbal commitments fail at scale; written ones survive procurement-handover.
6. Build the decision matrix
Score each finalist on six dimensions (price, MOQ, lead time, certification fit, format fit, audit history) with explicit weights. The shortlist owner takes the commercial relationship — at Lila Zebra we hand over the intelligence, not the negotiation.
Three sourcing approaches compared
| Approach | What it gives you | Where it breaks | When to use it |
|---|---|---|---|
| DIY sourcing Brand team runs the search |
Total control, lowest cash cost, internalised learning. | Eats 80-120 internal hours; brand team is exposed to under-qualified candidates pitching well; audit-checks rarely happen. | You have launched 3+ products with the same category before, or your team includes a category PM with CMO experience. |
| Sourcing broker / consultancy Third-party places you with a CMO |
Faster, less internal load. Broker handles outreach + negotiation. | Broker is paid by the manufacturer (often 3–8% of contract value), so incentive bias is real. Coverage is limited to the broker's network. | You need someone to actually run the negotiation, not just hand over the shortlist. |
| Intelligence-led shortlist e.g. Lila Zebra Supplier Matrix |
Pre-screened shortlist with audit history, certification stack, capacity and price indication. Brand team owns the relationship outright. | You still run the commercial conversation — we do not negotiate on your behalf. | You want an independent, source-traced overview before you invest your team's hours in conversations. |
Common mistakes we see in 2026
Five patterns come up repeatedly when brand-side teams brief us after a failed first attempt.
- Confusing certification with fit. Holding a certificate is not the same as being able to ship into your channel. The certificate matters, the audit history matters more, and the format-line match matters most.
- Underestimating raw-material lead times. Novel or hard-to-source ingredients (collagen peptides from specific marine sources, organic vitamin C from acerola, specific probiotic strains) can carry 12–20 week lead times of their own — invisible until you sign.
- Letting the manufacturer write the spec. A CMO will gladly close gaps in your specification — using the formula they happen to have running. The result is your label on someone else's product.
- Treating health claims as a label problem. EU Health Claims Regulation 1924/2006 is enforced at member-state level; a claim that survived in one EU market can be challenged by BVL in another. Treat claims as a regulatory-design problem from day one.
- Skipping the stability indication. A 24-month shelf-life claim without a stability study is a recall risk. Insist on a written indication, even if the full study comes later.
Regulatory landscape — what you must know in 2026
A non-exhaustive map of the relevant rule-set:
- EU food law: Regulation EC 178/2002 (horizontal), Directive 2002/46/EC (food supplements), Regulation EU 2017/625 (official controls).
- EU claims: Regulation EC 1924/2006 on nutrition and health claims; the EFSA-maintained register of approved Article 13(1) claims; Regulation EU 432/2012 listing 247 permitted Article 13 claims.
- EU novel foods: Regulation EU 2015/2283; the Union list of authorised novel foods (Regulation EU 2017/2470 as amended).
- Germany — supplements: Nahrungsergänzungsmittelverordnung (NemV) §5 notification to BVL; LFGB §11 prohibitions on misleading information; LMIDV (food information regulation) for labelling.
- Germany — pharmacy channel: §11a AMG manufacturer authorisation; PZN allocation via IFA; AMG cross-checks if presentation crosses into medicinal-product territory.
Frequently asked questions
What is a supplement co-manufacturer?
A supplement co-manufacturer — also called a contract manufacturer or CMO — produces food-supplement and dietary-supplement products on behalf of a brand owner. They operate under GMP standards, supply the finished good and typically handle filling, primary packaging and batch documentation; the brand owns the formula, label and trade relationship.
How long does it take to launch a supplement in Germany?
From signed spec to first batch out of the line, a realistic timeline is 12 to 24 weeks. Roughly: 4 weeks for shortlist and selection, 4 weeks for formulation and stability checks, 4–12 weeks for raw-material sourcing, and 2–4 weeks for production. Pharmacy-channel launches with §11a AMG registration add 6–12 weeks.
What is the minimum order quantity for German supplement CMOs?
MOQs in 2026 typically range from 5,000 to 50,000 units depending on format. Capsule and tablet MOQs cluster around 10,000 units. Gummy MOQs are higher (often 25,000 or more). A few specialist CMOs offer 1,000–3,000 unit pilot runs for an order surcharge.
Do I need BfArM registration for a food supplement?
Food supplements (Nahrungsergänzungsmittel) are regulated as food in Germany — not as medicines — so they do not require BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) approval. Notification is sent to the BVL via the §5 NemV process. A product is only routed through BfArM if it crosses into the medicinal-product category by function or presentation.
What is the difference between IFS Food and FSSC 22000 certification?
Both are GFSI-recognised food-safety certifications. IFS Food (International Featured Standards) is dominant among retailer-supplied food products in Germany, France and Italy. FSSC 22000 builds on ISO 22000 and is more common with industrial suppliers and B2B raw-material lines. Many German supplement CMOs hold both.
Can I use the same co-manufacturer for retail and pharmacy distribution?
Often yes, but the regulatory wrap differs. Pharmacy distribution (Apothekenkanal) typically requires §11a AMG registration of the manufacturer plus PZN-listing of the product, and many pharmacy-grade CMOs run a dedicated line. Retail-only products skip these steps but face stricter LFGB compliance on claims.
What does a Lila Zebra Supplier Matrix include?
A Supplier Matrix is a curated overview of co-manufacturers pre-screened against your specification, target certifications, audit profile and category fit. It includes capacity range, format coverage, certification stack and a published price indication where available. We do not perform outreach or RFQ collection — the brand takes the commercial relationship.
Sources
- European Union — Regulation (EC) No 1924/2006 on nutrition and health claims made on foods.
- European Union — Regulation (EU) 2015/2283 on novel foods.
- European Commission — Regulation (EU) 432/2012 listing permitted health claims (247 entries).
- Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (BVL) — supplement notification register under §5 NemV.
- Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) — distinction between food supplements and medicinal products.
- Statista — German food supplements market, retail value 2018-2024 series.
- IFS — International Featured Standards Food v8 audit framework.
- FSSC — FSSC 22000 v6 scheme documentation.